{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:07:28Z","timestamp":1789744048787,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"INL - International Iberian Nanotechnology Laboratory"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ultrasound"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Amyloidosis is a rare multi-system disease that can affect the heart. Recent advances have been made in finding successful treatments for these patients. Nonetheless, cardiac amyloidosis continues to carry high morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This case refers to a 52-year-old man presenting with signs and symptoms of heart failure. Electrocardiogram showed q waves in V1-V3 and T wave inversion in the inferior and lateral leads. Echocardiography revealed moderate concentric left ventricular hypertrophy, with preserved biventricular systolic function and no other changes. Cardiac magnetic resonance showed severe left ventricular hypertrophy and diffuse fibrosis, suggesting infiltrative cardiomyopathy. Given these findings, a diagnosis of amyloidosis was considered and complementary tests were requested. Laboratory tests showed elevation of Kappa light chains in urine, with normal serum light chains. Cardiac scintigraphy with Tec99m-DPD showed increased cardiac uptake. Genetic testing showed no clinically relevant variants in the TTR gene. Salivary gland and abdominal fat biopsy demonstrated no deposition of amyloid substance. Bone marrow evaluation demonstrated the presence of 0.8% plasma cells (99.2% clonal). Given that a high degree of suspicion remained, an endocardial biopsy was performed and immunohistochemical staining revealed deposits of kappa light chains, suggesting AL amyloidosis. However, in the course of the clinical investigation, the patient's condition progressively deteriorated. By the time AL amyloidosis was diagnosed and targeted therapy initiated, the patient was already severely debilitated, ultimately leading to a short-term fatal outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Comment<\/jats:title>\n                    <jats:p>Amyloidosis, often undiagnosed early, can severely affect multiple organs, particularly the heart, leading to poor prognosis without timely intervention. In this case, AL amyloidosis, a type where plasma cells produce amyloidogenic light chains, was identified. The patient\u2019s late diagnosis led to rapid progression and treatment with chemotherapy and steroids; however, his condition deteriorated quickly, resulting in a fatal outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40477-025-01020-z","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:43:45Z","timestamp":1745595825000},"page":"757-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A lost race against time\u2014a rare case of AL amyloidosis"],"prefix":"10.1007","volume":"29","author":[{"given":"In\u00eas","family":"Conde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Galv\u00e3o","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"1020_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100720","author":"C Varga","year":"2021","unstructured":"Varga C, Dorbala S, Lousada I, Polydefkis MJ, Wechalekar A, Maurer MS, Comenzo RL (2021) The diagnostic challenges of cardiac amyloidosis: a practical approach to the two main types. Blood Rev. https:\/\/doi.org\/10.1016\/j.blre.2020.100720","journal-title":"Blood Rev"},{"issue":"9","key":"1020_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ajh.24433","volume":"91","author":"MA Gertz","year":"2016","unstructured":"Gertz MA (2016) Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment. Am J Hematol 91(9):947\u2013956. https:\/\/doi.org\/10.1002\/ajh.24433","journal-title":"Am J Hematol"},{"key":"1020_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/asheducation-2012.1.595","volume":"2012","author":"G Merlini","year":"2012","unstructured":"Merlini G, Palladini G (2012) Differential diagnosis of monoclonal gammopathy of undetermined significance. Hematology Am Soc Hematol Educ Program 2012:595\u2013603. https:\/\/doi.org\/10.1182\/asheducation-2012.1.595","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1020_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.053","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Sharmila Dorbala AL (2016) (Light-chain) cardiac amyloidosis: a review of diagnosis and therapy. JACC state-of-the-art review. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.053","journal-title":"J Am Coll Cardiol"},{"key":"1020_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310704","author":"M Grogan","year":"2017","unstructured":"Grogan M, Dispenzieri A, Gertz M (2017) Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart. https:\/\/doi.org\/10.1136\/heartjnl-2016-310704","journal-title":"Heart"},{"key":"1020_CR6","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73:2872\u20132891. https:\/\/doi.org\/10.1016\/j.jcmg.2013.10.008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1020_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/heartjnl-2016-310704","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7(2):157\u2013165. https:\/\/doi.org\/10.1136\/heartjnl-2016-310704","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"1020_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","volume":"12","author":"A Martinez-Naharro","year":"2019","unstructured":"Martinez-Naharro A, Kotecha T, Norrington K et al (2019) Native T1 and extracellular volume in transthyretin amyloidosis. JACC Cardiovasc Imaging 12(5):810\u2013819. https:\/\/doi.org\/10.1016\/j.jcmg.2018.02.006","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"1020_CR9","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/archinte.1987.00370060035007","volume":"83","author":"M Hanna","year":"2008","unstructured":"Hanna M, Gertz MA, Dispenzieri A et al (2008) Utility of technetium-99m pyrophosphate scintigraphy in the evaluation of patients with amyloidosis. Mayo Clin Proc 83(12):1226\u20131230. https:\/\/doi.org\/10.1001\/archinte.1987.00370060035007","journal-title":"Mayo Clin Proc"},{"key":"1020_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01760-6","author":"S Dorbala","year":"2019","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2019) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Card Fail. https:\/\/doi.org\/10.1007\/s12350-019-01760-6","journal-title":"J Card Fail"},{"issue":"13","key":"1020_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","volume":"112","author":"RH Falk","year":"2005","unstructured":"Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112(13):2047\u20132060. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"issue":"10","key":"1020_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(10):2404\u20132412. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"issue":"5","key":"1020_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/leu.2010.60","volume":"20","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Durie BG, Rajkumar SV et al (2006) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 20(5):791\u2013803. https:\/\/doi.org\/10.1038\/leu.2010.60","journal-title":"Leukemia"},{"issue":"23","key":"1020_CR14","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood.2020006913","volume":"136","author":"G Palladini","year":"2020","unstructured":"Palladini G, Milani P, Merlini G (2020) Management of AL amyloidosis in 2020. Blood 136(23):2620\u20132627. https:\/\/doi.org\/10.1182\/blood.2020006913","journal-title":"Blood"},{"issue":"2","key":"1020_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","volume":"128","author":"G Palladini","year":"2016","unstructured":"Palladini G, Merlini G (2016) What is new in the diagnosis and management of light-chain amyloidosis? Blood 128(2):159\u2013168. https:\/\/doi.org\/10.1182\/blood-2016-01-629790","journal-title":"Blood"},{"issue":"1","key":"1020_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1182\/hematology.2021000305","volume":"2021","author":"S Bal","year":"2021","unstructured":"Bal S, Landau H (2021) AL amyloidosis: untangling new therapies. Hematol Am Soc Hematol Educ Program 2021(1):682\u2013688. https:\/\/doi.org\/10.1182\/hematology.2021000305","journal-title":"Hematol Am Soc Hematol Educ Program"}],"container-title":["Journal of Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-025-01020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40477-025-01020-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-025-01020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:32:22Z","timestamp":1789741942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40477-025-01020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s40477-025-01020-z","relation":{},"ISSN":["1876-7931"],"issn-type":[{"value":"1876-7931","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that consent for submission and publication of this case has been obtained from the patient and that the publication of this case has been approved by the institutions\u2019 Ethics Committee.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}